Skip to main content

and
  1. Article

    Open Access

    An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants

    The SARS-CoV-2 variants replacing the first wave strain pose an increased threat by their potential ability to escape pre-existing humoral protection. An angiotensin converting enzyme 2 (ACE2) decoy that compe...

    Shiho Tanaka, Gard Nelson, C. Anders Olson, Oleksandr Buzko in Scientific Reports (2021)